NUWE NASDAQ
Nuwellis, Inc.
1W: -10.6%
1M: -6.1%
3M: -78.9%
YTD: -61.7%
1Y: -78.4%
3Y: -100.0%
5Y: -100.0%
$0.69
-0.06 (-7.37%)
Weekly Expected Move ±21.4%
$0
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (50)
Nuwellis, Inc. (NASDAQ:NUWE) Sees Significant Decline in Short Interest
Short Interest in Nuwellis, Inc. (NASDAQ:NUWE) Rises By 86.1%
Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical
Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin
Short interest alert: Most and least shorted sub-$2B materials stocks in July 2026
Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy
Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow® Installations in Wisconsin
Nuwellis secures new U.S. patent for dual-lumen catheter technology
Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026
Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)
Nuwellis names Mike McCormick as CEO
Nuwellis Announces Closing of $6.0 Million Registered Public Offering
12 Health Care Stocks Moving In Monday's Pre-Market Session
Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
Nuwellis, Inc. Q1 2026 Earnings Call Summary
Nuwellis (NUWE) Q1 2026 Earnings Transcript
Nuwellis, Inc. Announces First Quarter 2026 Financial Results
Earnings Scheduled For May 12, 2026
Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026
Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting
Nuwellis gains USPTO approval for dual-lumen catheter patent
Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology
Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology
Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat
Nuwellis Completes Acquisition of Rendiatech
Nuwellis Completes Acquisition of Rendiatech
12 Health Care Stocks Moving In Wednesday's After-Market Session
Nuwellis (NUWE) Q4 2025 Earnings Call Transcript
Nuwellis GAAP EPS of -$1.50, revenue of $2.42M
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
Earnings Scheduled For March 10, 2026
Here are the major earnings before the open Tuesday
12 Health Care Stocks Moving In Monday's After-Market Session
Nuwellis Q4 Earnings Preview
Nuwellis Earnings Preview
Quant snapshot: Avino Silver & Gold, Harmony Gold lead strong buys as Angel Studios, Exagen lag
Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy
Nuwellis Appoints David A. McDonald and Martin J.
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
Nuwellis Appoints Carisa Schultz as Chief Financial Officer
Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market
Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy
Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare
Nuwellis Announces Changes to Board of Directors
Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy
Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings
Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.